These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22034035)

  • 1. Modification and labeling of AAV vector particles.
    Büning H; Bolyard CM; Hallek M; Bartlett JS
    Methods Mol Biol; 2011; 807():273-300. PubMed ID: 22034035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations.
    Boucas J; Lux K; Huber A; Schievenbusch S; von Freyend MJ; Perabo L; Quadt-Humme S; Odenthal M; Hallek M; Büning H
    J Gene Med; 2009 Dec; 11(12):1103-13. PubMed ID: 19777441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of efficient human blood progenitor-targeted recombinant adeno-associated viral vectors (AAV) by applying an AAV random peptide library on primary human hematopoietic progenitor cells.
    Sellner L; Stiefelhagen M; Kleinschmidt JA; Laufs S; Wenz F; Fruehauf S; Zeller WJ; Veldwijk MR
    Exp Hematol; 2008 Aug; 36(8):957-64. PubMed ID: 18495326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.
    Grimm D; Kern A; Pawlita M; Ferrari F; Samulski R; Kleinschmidt J
    Gene Ther; 1999 Jul; 6(7):1322-30. PubMed ID: 10455443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transduction of mouse bone marrow-derived dendritic cells by repetitive infection with self-complementary adeno-associated virus 6 combined with immunostimulatory ligands.
    Aldrich WA; Ren C; White AF; Zhou SZ; Kumar S; Jenkins CB; Shaw DR; Strong TV; Triozzi PL; Ponnazhagan S
    Gene Ther; 2006 Jan; 13(1):29-39. PubMed ID: 16136165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes.
    Arnold GS; Sasser AK; Stachler MD; Bartlett JS
    Mol Ther; 2006 Jul; 14(1):97-106. PubMed ID: 16624620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells.
    Stachler MD; Bartlett JS
    Gene Ther; 2006 Jun; 13(11):926-31. PubMed ID: 16482202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5.
    Lochrie MA; Tatsuno GP; Arbetman AE; Jones K; Pater C; Smith PH; McDonnell JW; Zhou SZ; Kachi S; Kachi M; Campochiaro PA; Pierce GF; Colosi P
    Virology; 2006 Sep; 353(1):68-82. PubMed ID: 16806384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring the AAV vector capsid for gene therapy.
    Vandenberghe LH; Wilson JM; Gao G
    Gene Ther; 2009 Mar; 16(3):311-9. PubMed ID: 19052631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recombinant adeno-associated virus vector related impurities].
    Diao Y; Wang Q; Xiao W; Xu R
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vectors selected from adeno-associated viral display peptide libraries for leukemia cell-targeted cytotoxic gene therapy.
    Michelfelder S; Lee MK; deLima-Hahn E; Wilmes T; Kaul F; Müller O; Kleinschmidt JA; Trepel M
    Exp Hematol; 2007 Dec; 35(12):1766-76. PubMed ID: 17920758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
    Wu Z; Asokan A; Samulski RJ
    Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of adeno-associated viral vectors in insect cells using triple infection: optimization of baculovirus concentration ratios.
    Aucoin MG; Perrier M; Kamen AA
    Biotechnol Bioeng; 2006 Dec; 95(6):1081-92. PubMed ID: 16952153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.
    Shi W; Bartlett JS
    Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
    Nicklin SA; Buening H; Dishart KL; de Alwis M; Girod A; Hacker U; Thrasher AJ; Ali RR; Hallek M; Baker AH
    Mol Ther; 2001 Sep; 4(3):174-81. PubMed ID: 11545607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a high-capacity hybrid vector: packaging of recombinant adenoassociated virus replicative intermediates in adenovirus capsids overcomes the limited cloning capacity of adenoassociated virus vectors.
    Gonçalves MA; Pau MG; de Vries AA; Valerio D
    Virology; 2001 Sep; 288(2):236-46. PubMed ID: 11601895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for encapsidation of prokaryotic sequences during recombinant adeno-associated virus production and their in vivo persistence after vector delivery.
    Chadeuf G; Ciron C; Moullier P; Salvetti A
    Mol Ther; 2005 Oct; 12(4):744-53. PubMed ID: 16023415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.